Vacuolating cytotoxin produced by avian pathogenic Escherichia coli.
The purpose of this study was to determine whether avian pathogenic Escherichia coli produced cytotoxic activity. Culture supernatants of 20 E. coli strains isolated from cellulitis lesions in chickens, five E. coli strains from avian septicemia, five from swollen head syndrome, and five from the feces of healthy chickens were incubated with primary chicken embryo fibroblast (CEF) cells, primary chicken kidney (PCK) cells, a quail fibroblast cell line (QT-35), and four mammalian cell lines (human epithelioid cervical carcinoma, African green monkey kidney, Chinese hamster ovary, and human larynx epidermoid carcinoma). Cytotoxicity was observed with supernatants from the 30 avian pathogenic strains on the two primary chicken cells (CEF and PCK). The highest dilution of culture supenatant that induced cytotoxic changes in 50% of the cells was 1/64. Supernatants from the five strains from normal feces were noncytotoxic, and none of the supernatants was cytotoxic for the QT-35 or the four mammalian cell lines. The cytotoxic effect, which was observed as early as 2 hr after exposure of the cells, was maximal at 6 hr and was evident as vacuolation, morphologically indistinguishable from that previously reported for culture supernatants of Helicobacter pylori. Like the activity in H. pylori, the cytotoxicity of the avian pathogenic strains was destroyed by heating at 70 C for 30 min and by exposure to proteolytic enzymes and was retained by filtration with a 100,000 molecular weight cut-off ultrafilter. Supernatants of two vacuolating cytotoxin-positive cultures of H. pylori failed to induce vacuolation of the CEF and PCK cells but caused the characteristic vacuolation in HeLa and Vero cells. The observations suggest that avian pathogenic E. coli produce a cytotoxin that is similar to the cytotoxin of H. pylori but may be specific for avian cells.
Salvadori
M R
MR
Departamento de Microbiologia e Imunologia, Instituto de Biologia, Universidade de Campinas, Sao Paulo, Brazil.
Yano
T
T
Carvalho
H E
HE
Parreira
V R
VR
Gyles
C L
CL
D000818:Animals; D001426:Bacterial Proteins / Q000494:pharmacology; D001427:Bacterial Toxins / Q000096:biosynthesis*; D016466:CHO Cells; D002460:Cell Line; D002481:Cellulitis / Q000382:microbiology / Q000662:veterinary; D002642:Chick Embryo; D002645:Chickens; D002522:Chlorocebus aethiops; D006224:Cricetinae; D003603:Cytotoxins / Q000096:biosynthesis*; D004926:Escherichia coli / Q000302:isolation & purification / Q000378:metabolism* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000382:microbiology / Q000662:veterinary*; D005243:Feces / Q000382:microbiology; D006367:HeLa Cells; D016480:Helicobacter pylori; D006358:Hot Temperature; D006801:Humans; D008970:Molecular Weight; D011201:Poultry Diseases / Q000382:microbiology*; D018805:Sepsis / Q000382:microbiology / Q000662:veterinary; D014407:Tumor Cells, Cultured; D014709:Vero Cells
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D003603:Cytotoxins; C074689:VacA protein, Helicobacter pylori